Literature DB >> 925883

Interaction of clofibrate with warfarin. I. Effect of clofibrate on the disposition of the optical enantiomorphs of warfarin.

T D Bjornsson, P J Meffin, T F Blaschke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 925883     DOI: 10.1007/bf01061730

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


× No keyword cloud information.
  21 in total

1.  CLINICAL OBSERVATIONS ON PATIENTS TREATED WITH ATROMID AND ANTICOAGULANTS.

Authors:  A S ROGEN; J CAMPBELLFERGUSON
Journal:  J Atheroscler Res       Date:  1963 Sep-Dec

2.  The stereoselective interaction of warfarin and metronidazole in man.

Authors:  R A O'Reilly
Journal:  N Engl J Med       Date:  1976-08-12       Impact factor: 91.245

3.  Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration.

Authors:  P B Andreasen; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1974-12       Impact factor: 6.875

4.  Studies on the interaction of warfarin and clofibrate in man.

Authors:  R A O'Reilly; M A Sahud; A J Robinson
Journal:  Thromb Diath Haemorrh       Date:  1972-04-30

5.  Effect of sodium chlorophenoxyisobutyrate on the binding of vitamin K antagonists to human albumin in vitro.

Authors:  J P Tillement; C Mattei; R Zini
Journal:  Experientia       Date:  1974-05-15

6.  Interaction of several coumarin compounds with human and canine plasma albumin.

Authors:  R A O'Reilly
Journal:  Mol Pharmacol       Date:  1971-03       Impact factor: 4.436

7.  Plasma half-lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man.

Authors:  D S Hewick; J McEwen
Journal:  J Pharm Pharmacol       Date:  1973-06       Impact factor: 3.765

8.  Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements.

Authors:  M F OLIVER; S D ROBERTS; D HAYES; J F PANTRIDGE; M M SUZMAN; I BERSOHN
Journal:  Lancet       Date:  1963-01-19       Impact factor: 79.321

9.  The displacement of phenylbutazone-14C and warfarin-14C from human albumin by various drugs and fatty acids.

Authors:  H M Solomon; J J Schrogie; D Williams
Journal:  Biochem Pharmacol       Date:  1968-01       Impact factor: 5.858

10.  Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect.

Authors:  A Yacobi; J A Udall; G Levy
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

View more
  4 in total

Review 1.  A comparative review of the adverse effects of treatments for hyperlipidaemia.

Authors:  A Steiner; B Weisser; W Vetter
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

Review 2.  Protein binding drug displacement interactions fact or fiction?

Authors:  J J MacKichan
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

Review 3.  Importance of drug enantiomers in clinical pharmacology.

Authors:  K Williams; E Lee
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

Review 4.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.